Results revealed that high expression of ARHGAP11A was significantly associated with a better prognosis in gastric cancer (OS HR = 0.7, p = 6.4e−04) (Figure 2C) and blood cancer (The cohort GSE12417, OS HR = 0.47, Cox p = 0.047) (Figure 2J). This evidence concerns the gene ARHGAP11A and hematopoietic and lymphoid system neoplasm.